Diagnosis of acute kidney injury: From classic parameters to new biomarkers

Contributions to Nephrology

Volumn 156, Issue , 2007, Pages 213-219

  Bonventre, Joseph V ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLGLUCOSAMINIDASE; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; CREATININE; CYSTATIN; CYSTATIN C; HAVCR1 PROTEIN, HUMAN; INTERLEUKIN 18; LCN2 PROTEIN, HUMAN; MEMBRANE PROTEIN; ONCOPROTEIN; UNCLASSIFIED DRUG; VIRUS RECEPTOR;

ACUTE KIDNEY FAILURE; ARTICLE; BLOOD; HUMAN; PREDICTION AND FORECASTING; PROGNOSIS; SENSITIVITY AND SPECIFICITY; URINE;

ACETYLGLUCOSAMINIDASE; ACUTE-PHASE PROTEINS; BIOLOGICAL MARKERS; CREATININE; CYSTATINS; HUMANS; INTERLEUKIN-18; KIDNEY FAILURE, ACUTE; MEMBRANE GLYCOPROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RECEPTORS, VIRUS; SENSITIVITY AND SPECIFICITY;

EID: 34247566245     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/0000102086     Document Type: Article

References (20)

1. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G: National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003;139:137-147.
2. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW: Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005;16:3365-3370.
3. Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, Bauer P, Hiesmayr M: Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 2004;15:1597-1605.
4. Bailly V, Zhang Z, Meier W, Cate R, Sanicola M, Bonventre JV: Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration. J Biol Chem 2002;277: 39739-39748.
5. Amin RP, Vickers AE, Sistare F, Thompson KL, Roman RJ, Lawton M, Kramer J, Hamadeh HK, Collins J, Grissom S, et al: Identification of putative gene based markers of renal toxicity. Environ Health Perspect 2004;112:465-479.
6. de Borst MH, van Timmeren MM, Vaidya VS, de Boer RA, van Dalen MB, Kramer AB, Schuurs TA, Bonventre JV, Navis G, van Goor H: Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase. Am J Physiol Renal Physiol 2007;292:F313-F320.
7. Ichimura T, Hung CC, Yang SA, Stevens JL, Bonventre JV: Kidney injury molecule-1:a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol 2004;286:F552-F563.
8. Vaidya VS, Ramirez V, Ichimura T, Bobadilla NA, Bonventre JV: Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol 2006;290:F517-F529.
9. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV: Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 2002;62:237-244.
10. Liangos O, Perianayagam MC, Vaidya VS, Han WK, Wald R, Tighiouart H, Mackinnon RW, Li L, Balakrishnan VS, Pereira BJ, et al: Urinary N-acetyl-{beta}-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol 2007;Epub ahead of print.
11. Wiley RA, Choo HY, Traiger GJ: The effect of nephrotoxic furans on urinary N-acetylglucosaminidase levels in mice. Toxicol Lett 1982;14:93-96.
12. Vaidya VS, Shankar K, Lock EA, Bucci TJ, Mehendale HM: Renal injury and repair following S-1,2 dichlorovinyl-L-cysteine administration to mice. Toxicol Appl Pharmacol 2003;188:110-121.
13. Schmidt-Ott KM, Mori K, Li JY, Kalandadze A, Cohen DJ, Devarajan P, Barasch J: Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 2007;18:407-413.
14. Parikh CR, Jani A, Mishra J, Ma Q, Kelly C, Barasch J, Edelstein CL, Devarajan P: Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant 2006;6:1639-1645.
15. Filler G, Bokenkamp A, Hofmann W, Le Bricon T, Martinez-Bru C, Grubb A: Cystatin C as a marker of GFR-history, indications, and future research. Clin Biochem 2005;38:1-8.
16. Preiss DJ, Godber IM, Lamb EJ, Dalton RN, Gunn IR: The influence of a cooked-meat meal on estimated glomerular filtration rate. Ann Clin Biochem 2007;44:35-42.
17. Herget-Rosenthal S, Poppen D, Husing J, Marggraf G, Pietruck F, Jakob HG, Philipp T, Kribben A: Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. Clin Chem 2004;50:552-558.
18. Liano F, Junco E, Pascual J, Madero R, Verde E: The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute Renal Failure Study Group. Kidney Int Suppl 1998;66:S16-S24.
19. Parikh CR, Jani A, Melnikov VY, Faubel S, Edelstein CL: Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis 2004;43:405-414.
20. Parikh CR, Mishra J, Thiessen-Philbrook H, Dursun B, Ma Q, Kelly C, Dent C, Devarajan P, Edelstein CL: Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int 2006;70:199-203.